Skip to product information
1 of 1
Out of Stock

Glinext Mr (Gliclazide) 30mg, 30 Ct - Next Pharma

Glinext Mr (Gliclazide) 30mg, 30 Ct - Next Pharma

Regular price PKR 389
Regular price Sale price PKR 389
Out of Stock
Pack Size: 30 Modified Released Tablets
Glinext MR (Modified Release) is a prescription oral anti-diabetic medicine containing Gliclazide 30 mg, a second-generation sulfonylurea. It is used to lower blood glucose levels in adults with type 2...  Read More
SKU: 08961102450679
Country: Pakistan
View full details

Description

Glinext MR (Modified Release) is a prescription oral anti-diabetic medicine containing Gliclazide 30 mg, a second-generation sulfonylurea. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus when diet, physical exercise, and weight loss alone are insufficient to control blood sugar.

The modified‑release formulation releases the active ingredient gradually over 24 hours, providing once‑daily blood sugar control that aligns with the natural circadian glucose profile. Gliclazide works by stimulating insulin secretion from the pancreatic beta‑cells and by improving the body’s sensitivity to its own insulin, helping to lower blood glucose levels and reduce the risk of long‑term diabetic complications

  • Lowers Blood Sugar – Stimulates insulin production from the pancreas for better glucose control
  • Improves Insulin Response – Enhances the body’s natural insulin function and reduces insulin resistance
  • Helps Prevent Diabetes Complications – Supports the reduction of nerve damage, kidney issues, and cardiovascular problems associated with uncontrolled diabetes

Composition
Each modified released tablet contains:

  • Gliclazide: 30 mg

Directions for Use

  • Use as directed by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.

Collapsible content

Product Overview

Glinext MR (Modified Release) is a prescription oral anti-diabetic medicine containing Gliclazide 30 mg, a second-generation sulfonylurea. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus when diet, physical exercise, and weight loss alone are insufficient to control blood sugar.

The modified‑release formulation releases the active ingredient gradually over 24 hours, providing once‑daily blood sugar control that aligns with the natural circadian glucose profile. Gliclazide works by stimulating insulin secretion from the pancreatic beta‑cells and by improving the body’s sensitivity to its own insulin, helping to lower blood glucose levels and reduce the risk of long‑term diabetic complications

  • Lowers Blood Sugar – Stimulates insulin production from the pancreas for better glucose control
  • Improves Insulin Response – Enhances the body’s natural insulin function and reduces insulin resistance
  • Helps Prevent Diabetes Complications – Supports the reduction of nerve damage, kidney issues, and cardiovascular problems associated with uncontrolled diabetes

Composition
Each modified released tablet contains:

  • Gliclazide: 30 mg

Directions for Use

  • Use as directed by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.

Product Overview

Glinext MR (Modified Release) is a prescription oral anti-diabetic medicine containing Gliclazide 30 mg, a second-generation sulfonylurea. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus when diet, physical exercise, and weight loss alone are insufficient to control blood sugar.

The modified‑release formulation releases the active ingredient gradually over 24 hours, providing once‑daily blood sugar control that aligns with the natural circadian glucose profile. Gliclazide works by stimulating insulin secretion from the pancreatic beta‑cells and by improving the body’s sensitivity to its own insulin, helping to lower blood glucose levels and reduce the risk of long‑term diabetic complications

  • Lowers Blood Sugar – Stimulates insulin production from the pancreas for better glucose control
  • Improves Insulin Response – Enhances the body’s natural insulin function and reduces insulin resistance
  • Helps Prevent Diabetes Complications – Supports the reduction of nerve damage, kidney issues, and cardiovascular problems associated with uncontrolled diabetes

Composition
Each modified released tablet contains:

  • Gliclazide: 30 mg

Directions for Use

  • Use as directed by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.